Bo Nilsson Selected Research

Peptide Hydrolases (Proteases)

10/2019	Is generation of C3(H2O) necessary for activation of the alternative pathway in real life?
1/2018	Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Nilsson Research Topics

Disease

35	Inflammation (Inflammations) 01/2023 - 09/2005
16	Neoplasms (Cancer) 02/2021 - 04/2002
11	Thromboinflammation 01/2021 - 01/2013
10	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 12/2010
9	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 06/2005
9	COVID-19 08/2022 - 11/2020
9	Infections 06/2022 - 06/2004
8	Sepsis (Septicemia) 01/2022 - 08/2002
7	Colorectal Neoplasms (Colorectal Cancer) 05/2019 - 07/2003
7	Prostatic Neoplasms (Prostate Cancer) 06/2010 - 02/2005
6	Wounds and Injuries (Trauma) 12/2021 - 01/2017
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2016 - 08/2003
5	Thrombosis (Thrombus) 01/2022 - 09/2009
5	Melanoma (Melanoma, Malignant) 02/2011 - 05/2005
4	Reperfusion Injury 12/2023 - 06/2015
4	Hemolysis 10/2023 - 03/2002
4	Hereditary Complement Deficiency Diseases 01/2023 - 09/2007
4	Critical Illness (Critically Ill) 06/2022 - 12/2020
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2019
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 11/2020
3	Burns 12/2021 - 11/2017
3	Hemorrhagic Shock 01/2020 - 01/2019
3	Multiple Trauma (Multiple Injuries) 01/2019 - 11/2010
3	Arteriosclerosis 01/2018 - 01/2007
3	Multiple Sclerosis 01/2016 - 01/2013
3	Carcinoma (Carcinomatosis) 07/2008 - 06/2005
2	Atypical Hemolytic Uremic Syndrome 10/2023 - 10/2019
2	Thromboembolism 10/2023 - 01/2022
2	Rheumatoid Arthritis 01/2023 - 05/2007
2	Vascular Diseases (Vascular Disease) 11/2020 - 06/2020
2	Thrombocytopenia (Thrombopenia) 01/2019 - 08/2006
2	Stroke (Strokes) 01/2019 - 01/2007
2	Heart Failure 01/2018 - 01/2017
2	Macular Degeneration (Age-Related Maculopathy) 01/2017 - 09/2007
2	Septic Shock (Toxic Shock Syndrome) 01/2017 - 08/2002
2	Diabetes Mellitus 11/2016 - 10/2014
2	Ischemia 01/2016 - 10/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015 - 06/2014
2	Obesity 09/2015 - 06/2014
2	Insulin Resistance 09/2015 - 11/2005
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2014 - 01/2011
2	Alzheimer Disease (Alzheimer's Disease) 11/2013 - 01/2013

Drug/Important Bio-Agent (IBA)

51	Complement System Proteins (Complement)IBA 01/2024 - 03/2002
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2004
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2011
8	CytokinesIBA 06/2022 - 09/2004
7	Biocompatible Materials (Biomaterials)IBA 01/2022 - 01/2007
6	AutoantibodiesIBA 01/2024 - 01/2008
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2019 - 01/2004
5	Monoclonal AntibodiesIBA 11/2020 - 07/2003
4	Complement C3 (C3 Complement)IBA 08/2022 - 04/2010
4	Kallikreins (Kallikrein)IBA 01/2022 - 11/2016
4	KininsIBA 01/2022 - 11/2016
4	Heparin (Liquaemin)FDA LinkGeneric 04/2016 - 02/2010
3	LectinsIBA 01/2024 - 10/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2004
3	AntibodiesIBA 01/2024 - 01/2019
3	Thrombin FDA Link 01/2023 - 11/2010
3	compstatinIBA 08/2022 - 01/2019
3	Immunoglobulin G (IgG)IBA 06/2022 - 06/2005
3	ChemokinesIBA 01/2022 - 06/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2020
3	AntithrombinsIBA 03/2015 - 04/2004
3	Fluorouracil (Carac)FDA LinkGeneric 01/2009 - 10/2003
3	EnzymesIBA 03/2007 - 08/2002
2	LipopolysaccharidesIBA 01/2023 - 01/2020
2	AMY-101IBA 08/2022 - 11/2020
2	Immunoglobulin M (IgM)IBA 06/2022 - 06/2005
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2022 - 12/2020
2	complement C3d,gIBA 01/2021 - 05/2007
2	InterleukinsIBA 01/2021 - 06/2005
2	fibrin fragment D (D-dimer)IBA 01/2021 - 12/2020
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 10/2019 - 01/2018
2	Carcinoembryonic AntigenIBA 05/2019 - 01/2004
2	LipidsIBA 01/2019 - 04/2016
2	Therapeutic UsesIBA 01/2019 - 09/2004
2	Fibrinogen (Factor I)FDA Link 01/2019 - 04/2004
2	Complement Inactivating AgentsIBA 01/2019 - 09/2009
2	PolymersIBA 01/2019 - 01/2016
2	glimepiride (Amarel)FDA LinkGeneric 01/2018 - 01/2017
2	Liraglutide FDA Link 01/2018 - 01/2017
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2017
2	AnaphylatoxinsIBA 01/2017 - 09/2015
2	Peptides (Polypeptides)IBA 04/2016 - 11/2009
2	Blood Glucose (Blood Sugar)IBA 03/2015 - 06/2014
2	Insulin (Novolin)FDA Link 01/2015 - 02/2010
2	ButyrylcholinesteraseIBA 01/2015 - 11/2013
2	Antigen-Antibody Complex (Immune Complex)IBA 03/2011 - 09/2010
2	AutoantigensIBA 04/2010 - 06/2005

Therapy/Procedure

18	Therapeutics 10/2023 - 10/2003
9	Transplantation 01/2019 - 12/2011
4	Immunotherapy 01/2009 - 06/2005
3	Radiotherapy 01/2009 - 10/2004
3	Prostatectomy (Retropubic Prostatectomy) 10/2008 - 11/2005
2	Kidney Transplantation 12/2023 - 12/2018
2	Critical Care (Surgical Intensive Care) 06/2022 - 01/2022
2	Renal Dialysis (Hemodialysis) 08/2021 - 01/2007
2	Stents 06/2020 - 01/2007
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2015 - 08/2011